[PDF] EU-RISK MANAGEMENT PLAN FOR REVLIMID (LENALIDOMIDE)

Từ khóa » Cc-5013-nhl-007

• Rituximab Plus Lenalidomide For Patients With Relapsed ...

• [PDF] CELGENE PROPRIETARY INFORMATION

• EU Clinical Trials Register

• A Phase III Study Of Lenalidomide Plus Rituximab Versus Placebo ...

• Celgene-cc-5013-nhl-007 By Gibbs - Issuu

• Clinical Trials - Mayo Foundation For Medical Education And Research

• Revlimid 5 Mg Hard Capsules - Summary Of Product Characteristics ...

• [PDF] Lenalidomide-accord-epar-product-information_en.pdf

• Lenalidomide - Celgene Corporation - AdisInsight - Springer

• ICTRP Search Portal

• [PDF] Revlimid, INN-lenalidomide - European Medicines Agency

• Lenalidomide Lymphoma MAGNIFY (CC-5013-NHL-008)

• Lymphoma & Myeloma Clinical Trials | MD Anderson Cancer Center

• [PDF] SMC2281 - Scottish Medicines Consortium